374
Participants
Start Date
January 31, 2012
Primary Completion Date
December 31, 2015
Study Completion Date
September 30, 2016
Qiliqiangxin capsule
Qiliqiangxin capsule is administrated based on the standard heart failure treatment in China. Dosage: 1.2g/times. Frequency: 3 times/day. Duration: The whole study period.
Placebo
Placebo, similar in color and taste to Qiliqiangxin capsule, is administrated based on the standard heart failure treatment in China. Dosage: 1.2g/times. Frequency: 3 times/day. Duration: The whole study period.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Fudan University
OTHER
First Affiliated Hospital of Harbin Medical University
OTHER
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Shandong Provincial Hospital
OTHER_GOV
The First Affiliated Hospital with Nanjing Medical University
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
The First Affiliated Hospital of Zhengzhou University
OTHER
Ministry of Science and Technology of the People´s Republic of China
OTHER_GOV
China National Center for Cardiovascular Diseases
OTHER_GOV
RenJi Hospital
OTHER
Second Affiliated Hospital of Xi'an Jiaotong University
OTHER
The Second Affiliated Hospital of Harbin Medical University
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Tongji Hospital
OTHER
Wuhan University
OTHER
Henan Provincial People's Hospital
OTHER
Jining Medical University
OTHER
Second Hospital of Shanxi Medical University
OTHER
Shanxi Cardiovascular Hospital
OTHER
Wuhan Pu-Ai Hospital
OTHER
Tianyou Hospital Affiliated to Wuhan University of Science and Technology
OTHER
Yunyang Medical College
OTHER
China Three Gorges University, Yichang, China
OTHER
Xiangyang Central Hospital
OTHER
Wuhan No.1 Hospital
OTHER
Jingzhou Central Hospital
OTHER
Huazhong University of Science and Technology
OTHER